A small group of people suffering from rectal cancer underwent a study. 18 patients in a small clinical trial at Memorial Sloan Kettering Cancer Center in Manhattan, US took the drug Dostarlimab for almost 6 months. As per the results observed, their ...
from Google Alert - health https://ift.tt/APd4R1B
via IFTTT
0 comments:
Post a Comment